NasdaqGS - Nasdaq Real Time Price USD

Mesa Laboratories, Inc. (MLAB)

Compare
130.95 +2.40 (+1.87%)
At close: October 15 at 4:00 PM EDT
130.01 -0.94 (-0.72%)
Pre-Market: 8:02 AM EDT
Loading Chart for MLAB
DELL
  • Previous Close 128.55
  • Open 127.35
  • Bid 129.93 x 100
  • Ask 131.74 x 100
  • Day's Range 127.35 - 131.87
  • 52 Week Range 82.86 - 141.17
  • Volume 24,718
  • Avg. Volume 31,975
  • Market Cap (intraday) 709.06M
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) --
  • EPS (TTM) -46.47
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield 0.64 (0.49%)
  • Ex-Dividend Date Nov 29, 2024
  • 1y Target Est 143.33

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

www.mesalabs.com

736

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MLAB

View More

Performance Overview: MLAB

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MLAB
25.51%
S&P 500
21.92%

1-Year Return

MLAB
29.85%
S&P 500
34.37%

3-Year Return

MLAB
57.10%
S&P 500
31.03%

5-Year Return

MLAB
39.01%
S&P 500
96.05%

Compare To: MLAB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MLAB

View More

Valuation Measures

Annual
As of 6/10/2024
  • Market Cap

    695.13M

  • Enterprise Value

    888.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.16

  • Price/Book (mrq)

    4.70

  • Enterprise Value/Revenue

    4.03

  • Enterprise Value/EBITDA

    305.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -111.89%

  • Return on Assets (ttm)

    1.24%

  • Return on Equity (ttm)

    -92.97%

  • Revenue (ttm)

    223.71M

  • Net Income Avi to Common (ttm)

    -250.31M

  • Diluted EPS (ttm)

    -46.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.99M

  • Total Debt/Equity (mrq)

    146.95%

  • Levered Free Cash Flow (ttm)

    56.69M

Research Analysis: MLAB

View More

Company Insights: MLAB

Research Reports: MLAB

View More

People Also Watch